Healthcare · Pharmaceutical spending per capita
France spends 700 $ per capita on pharmaceutical products in 2026, ranking 19-th globally. This high expenditure level is driven not only by the cost of innovative drugs but also by the French culture of medication use: the country is among the world leaders in antibiotic and psychotropic drug consumption. The major pharmaceutical clusters—Île-de-France and the Lyon region—drive the development and production of a significant share of the medicines consumed domestically.
Data for 2026 · unit: $
Position
#19 / 197
France world ranking
Country position on the scale from last to first place for this indicator.
FR
#19
#197#1
Trend
Change over time
Change in indicator over the available period.
250
1990
400
2000
550
2010
650
2020
700
2026
Values — $
Comparison
Top countries by Pharmaceutical spending per capita
Where France stands in the world ranking.
1
MCMonaco
1.9 K
2
USUSA
1.4 K
3
LILiechtenstein
1.3 K
4
LULuxembourg
1.2 K
5
JPJapan
950
5
CACanada
950
7
CHSwitzerland
920
8
SMSan Marino
850
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical spending per capita in France — how much?
Based on 2026 data — 700 $. This is rank #19 out of 197 countries.
What is France's rank by Pharmaceutical spending per capita?
France ranks #19 out of 197 countries in the world ranking by «Pharmaceutical spending per capita».
How has Pharmaceutical spending per capita changed in France?
Over the available period the indicator changed from 250 to 700 $.